ATAI
ATAI
NASDAQ · Pharmaceuticals

Ataibeckley Inc

$3.50
-0.04 (-1.13%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +1,055.4% upside
Low Target $27.58
Average Target $40.44
High Target $50.46
Current Price $3.50
Current
$3.50
Target
$40.44
$27.58 $40.44 avg $50.46
Scenario Analysis
Bear Case
$27.58
688.0%
Low target
Base Case
$40.44
+1,055.4%
Avg target
Bull Case
$50.46
+1,341.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.75
-48.1% from high
52-Week Low
$1.15
+204.3% from low
Target vs 52W High
$40.44
+499.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%